Drug:
Reaction: VOMITING
20260101 - 20261231
No. 701 - 800
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 701 | 26909843 |
US |
51 | 2 |
Hypertension, Nausea, Vomiting, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 702 | 26909868 |
CA |
40 | 2 |
Drug-induced liver injury, Wound infection, Infusion related reaction, Osteoarthritis, Gait inability, Type 2 diabetes mellitus, Adverse reaction, Abdominal pain upper, Nausea, Asthenia, Dizziness, Neck pain, Underdose, Coeliac disease, Joint swelling, Obesity, Hypersensitivity, Hypertension, Folliculitis, Facet joint syndrome, Lung disorder, Psoriatic arthropathy, Grip strength decreased, Muscular weakness, Swelling, Rheumatoid arthritis, Malaise, Confusional state, Drug hypersensitivity, Insomnia, Liver function test increased, Treatment failure, Arthropathy, Night sweats, Blister, Breast cancer stage III, Gastrooesophageal reflux disease, Drug intolerance, Depression, Rash, Blood cholesterol increased, Hepatitis, Gastrointestinal disorder, Contusion, Weight increased, Injection site reaction, Hand deformity, Dyspepsia, Glossodynia, Joint range of motion decreased, Muscle spasms, Musculoskeletal stiffness, Fatigue, Vomiting, Wound, Helicobacter infection, Drug ineffective, Exposure during pregnancy, Maternal exposure during pregnancy, Intentional product use issue, Off label use, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CANDESARTAN, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ERENUMAB-AOOE, |
||||
| 703 | 26909915 |
EU |
63 | 1 |
Hyperlactacidaemia, Abdominal pain upper, Vomiting, Dyspnoea, Metabolic acidosis, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, |
||||
| 704 | 26909923 |
|||
Pneumonia aspiration, Dysphagia, Vomiting, |
||||
QUETIAPINE, QUETIAPINE, CLOZAPINE, RISPERIDONE, VALPROIC ACID, |
||||
| 705 | 26909982 |
EU |
34 | 2 |
Muscular weakness, Vomiting, Seizure, Activities of daily living decreased, |
||||
OFATUMUMAB, |
||||
| 706 | 26909996 |
JP |
78 | 1 |
Hypoalbuminaemia, Ascites, Abdominal pain, Nausea, Vomiting, Oedema peripheral, |
||||
CAPECITABINE, CAPECITABINE, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, ZOLBETUXIMAB, OXALIPLATIN, OXALIPLATIN, |
||||
| 707 | 26910009 |
US |
40 | 2 |
Fatigue, Nausea, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 708 | 26910022 |
US |
26 | |
Hypoacusis, Cold sweat, Muscle tightness, Hyperhidrosis, Pallor, Dizziness, Nausea, Vomiting, |
||||
BUROSUMAB, BUROSUMAB, |
||||
| 709 | 26910048 |
84 | 2 | |
Drug tolerance decreased, Hypercalcaemia, Nausea, Vomiting, |
||||
CINACALCET, CINACALCET, |
||||
| 710 | 26910142 |
NP |
17 | |
Multiple organ dysfunction syndrome, Suicide attempt, Loss of consciousness, Acute kidney injury, Hyperkalaemia, Mitochondrial cytopathy, Tachycardia, Hypoperfusion, Haemodynamic instability, Toxicity to various agents, Mental status changes, Hypotension, Lactic acidosis, Vomiting, Abdominal pain, Hypoglycaemia, Metabolic acidosis, Intentional overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 711 | 26910168 |
US |
41 | 1 |
Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 712 | 26910237 |
BR |
2 | |
Suicide attempt, Suicidal ideation, Asthenia, Pain, Feeling abnormal, Headache, Wound, Pruritus, Asphyxia, Neoplasm, Tumour pain, Apathy, Syncope, Swelling, Renal impairment, Cardiac arrest, Eye disorder, Cardiac arrest, Coronavirus infection, Pneumonia, Neoplasm malignant, Cardiomegaly, Neoplasm malignant, Pancreatic enlargement, Abnormal organ growth, Metastatic carcinoid tumour, Throat cancer, Metastasis, Metastasis, Disease recurrence, Metastases to bone, Diabetes mellitus, Arrhythmia, Acromegaly, Bone pain, Visual impairment, Bone marrow infiltration, Nervousness, Malaise, Cataract, Mass, Lung disorder, Bone disorder, Back pain, Agitation, Insomnia, Panic reaction, Feeding disorder, Fear, Fatigue, Stress, Skin hypertrophy, Skin discolouration, Balance disorder, General physical condition abnormal, Hepatomegaly, Crying, Mood altered, Endocrine disorder, Deformity, Dyskinesia, Fall, Foot deformity, Dysphonia, Needle issue, Productive cough, Dyspnoea, Influenza like illness, Headache, Oropharyngeal pain, Incorrect dose administered, Product quality issue, Product storage error, Product physical issue, Inappropriate schedule of product administration, Muscular weakness, Myalgia, Coating in mouth, Hormone level abnormal, Therapeutic product effect delayed, Dyspnoea, Cardiac disorder, Tongue disorder, Liver disorder, Pancreatic disorder, Gallbladder disorder, Headache, Vomiting, Injection site pain, Decreased appetite, Bacteroides test positive, Head injury, Malaise, Retching, Cyanosis, Cardiac valve disease, Asthenia, Sluggishness, Platelet count decreased, Decreased immune responsiveness, Haemangioma of bone, Neuralgia, Anxiety, Gait disturbance, Malaise, Pyrexia, Yellow skin, Skin discolouration, Gait disturbance, Laziness, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, SERTRALINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 713 | 26910325 |
US |
29 | 2 |
Foreign body in throat, Abdominal distension, Gastrooesophageal reflux disease, Vomiting, Nausea, |
||||
DUPILUMAB, BUPROPION, FLUOXETINE HYDROCHLORIDE, DROSPIRENONE AND ETHINYL ESTRADIOL, |
||||
| 714 | 26910382 |
EU |
58 | 2 |
Hypertension, Nausea, Vomiting, Dizziness, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
| 715 | 26910423 |
JP |
78 | 2 |
Decreased appetite, Vomiting, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LINAGLIPTIN, |
||||
| 716 | 26910443 |
BR |
64 | 2 |
Pancreatitis acute, Abdominal pain upper, Transient ischaemic attack, Psoriasis, Psoriatic arthropathy, Pyrexia, Malaise, Panic disorder, Anxiety, Cellulitis, Hyperhidrosis, Dizziness, Malaise, Tremor, Dyspnoea, Illness, Dizziness, Uterine cervix atrophy, Drug hypersensitivity, Rebound psoriasis, Skin plaque, Liver disorder, Blood pressure abnormal, Memory impairment, Ischaemia, Feeling abnormal, Feeling hot, Tremor, Vomiting, Depressed mood, Teeth brittle, Swelling, Rash erythematous, Skin sensitisation, Fall, Head injury, Oedema, Back disorder, Fatigue, Fibromyalgia, Intervertebral disc degeneration, Scar, Toothache, Abdominal pain upper, Infection, Reflux gastritis, Arthralgia, Muscle spasms, Fear, Pain in extremity, Pain, Emotional distress, Tooth infection, Drug ineffective, Product availability issue, Product dose omission issue, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, ACITRETIN, CALCIUM, LOSARTAN, SIMVASTATIN, AMITRIPTYLINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 717 | 26910513 |
US |
2 | |
Discomfort, Eructation, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 718 | 26910521 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 719 | 26910616 |
US |
||
Vomiting, Diarrhoea, |
||||
TROFINETIDE, |
||||
| 720 | 26910682 |
EU |
72 | 2 |
Nausea, Vomiting, Drug intolerance, Diarrhoea, |
||||
IRINOTECAN HYDROCHLORIDE, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 721 | 26910700 |
CN |
43 | 1 |
Atrial fibrillation, Palpitations, Nausea, Tachycardia, Vomiting, Wrong technique in product usage process, Anxiety, |
||||
| 722 | 26910768 |
EU |
91 | 2 |
Vomiting, Dizziness, Diarrhoea, Haematemesis, |
||||
CAPECITABINE, |
||||
| 723 | 26910912 |
CA |
44 | 2 |
Wound infection, Therapeutic product effect decreased, Hepatic enzyme increased, Wound, Underdose, Maternal exposure during pregnancy, White blood cell count increased, Joint swelling, Intentional product use issue, Therapy non-responder, X-ray abnormal, Dizziness, Adverse drug reaction, Duodenal ulcer perforation, Maternal exposure timing unspecified, Peripheral swelling, Contraindicated product administered, Porphyria acute, Product use in unapproved indication, Live birth, Oedema, Wheezing, Mobility decreased, Sinusitis, Product use issue, Rectal haemorrhage, Medication error, Rash, Hypersensitivity, Discomfort, Abdominal discomfort, Arthropathy, Off label use, Arthralgia, Lower respiratory tract infection, Drug ineffective, Musculoskeletal stiffness, Nausea, Treatment failure, Prescribed overdose, Vomiting, Pancreatitis, Pruritus, Synovitis, Rheumatoid factor positive, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, FOLIC ACID, RITUXIMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, METHOTREXATE SODIUM, |
||||
| 724 | 26910930 |
GB |
2 | |
Lower respiratory tract infection, Injection site erythema, Influenza like illness, Vomiting, Asthenia, Illness, Influenza, Chest discomfort, Feeling abnormal, Influenza like illness, Nausea, Palpitations, Malaise, Pyrexia, Influenza, Dizziness, Asthenia, Pain, Chest discomfort, Weight decreased, Paraesthesia, Ocular discomfort, Head discomfort, Urinary tract infection, Influenza like illness, Nausea, |
||||
OFATUMUMAB, OFATUMUMAB, |
||||
| 725 | 26910941 |
EU |
50 | 2 |
Malaise, Abdominal pain upper, Vomiting, |
||||
CELECOXIB, |
||||
| 726 | 26911088 |
GB |
53 | 1 |
Haematochezia, Diarrhoea, Pyrexia, Vomiting, Decreased appetite, Abdominal pain, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, POLATUZUMAB VEDOTIN, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 727 | 26911198 |
CN |
77 | 2 |
Neoplasm progression, Nausea, Vomiting, |
||||
CAPECITABINE, |
||||
| 728 | 26911265 |
US |
49 | 1 |
Dyspepsia, Nausea, Vomiting, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 729 | 26911519 |
US |
80 | |
Impaired gastric emptying, Nausea, Vomiting, Diarrhoea, Abdominal pain, |
||||
DULAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 730 | 26911585 |
CA |
65 | 2 |
Wheezing, Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, |
||||
ROPIVACAINE HYDROCHLORIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMINOPHYLLINE, BECLOMETHASONE DIPROPIONATE, CALCIUM CARBONATE, ANTACID, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, CEFADROXIL, CEFADROXIL, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, |
||||
| 731 | 26911625 |
US |
31 | 1 |
Seizure, Product use in unapproved indication, Overdose, Product dose omission issue, Vomiting, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 732 | 26911672 |
US |
45 | 1 |
Cold sweat, Vomiting, |
||||
CAPECITABINE, |
||||
| 733 | 26911680 |
CA |
60 | 2 |
Back pain, Treatment failure, Nausea, Anal incontinence, Condition aggravated, Constipation, Vomiting, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, |
||||
| 734 | 26911683 |
GB |
2 | |
Blood ketone body increased, Vomiting, Blood glucose abnormal, |
||||
DIMETHYL FUMARATE, |
||||
| 735 | 26911723 |
CN |
16 | 2 |
Gastritis, Chills, Nausea, Vomiting, Diarrhoea, Toxicity to various agents, |
||||
SERTRALINE, |
||||
| 736 | 26911841 |
US |
15 | |
Vomiting, Headache, Visual impairment, |
||||
ISOTRETINOIN, |
||||
| 737 | 26911913 |
CO |
54 | 2 |
Arrhythmia, Arthralgia, Pain in extremity, Headache, Eye pain, Vision blurred, Vertigo, Loss of personal independence in daily activities, Nausea, Vomiting, Diarrhoea, Musculoskeletal pain, Viral infection, Swelling, Gastrooesophageal reflux disease, Hiatus hernia, Gastritis, Product dose omission issue, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ERGOCALCIFEROL, VITAMIN E, LEVOTHYROXINE SODIUM, FLUTICASONE FUROATE, ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 738 | 26911919 |
CA |
59 | 2 |
Blood pressure increased, Syncope, Blood iron decreased, Cystitis, Cellulitis, Back pain, Neuralgia, Pain, Hypoaesthesia, Paraesthesia, Diabetes mellitus, Cholelithiasis, Haemorrhage, Hypothyroidism, Endometrial cancer stage I, Second primary malignancy, Nephrolithiasis, Renal impairment, Renal failure, Procedural pain, Carcinoid tumour, Metastases to ovary, Metastases to fallopian tube, Metastases to bladder, Malignant neoplasm progression, Palpitations, Arthralgia, Subcutaneous haematoma, Pain in extremity, Muscle spasms, Peripheral swelling, Serum serotonin increased, Vertigo, Urine output decreased, Myalgia, Contusion, Hepatic pain, Muscle tightness, Groin pain, Nasopharyngitis, White blood cell count increased, Haemoglobin decreased, Urinary tract infection, Acne, Liver function test increased, Hypomenorrhoea, Polyp, Blood urine present, Abdominal adhesions, Endometriosis, Endometrial hyperplasia, Poor quality sleep, Pyrexia, Chills, Cough, Migraine, Anaemia, Blood pressure systolic decreased, Blood pressure diastolic decreased, Joint swelling, Arthritis, Crystal arthropathy, Gout, Joint stiffness, Malaise, Peripheral swelling, Erythema, Joint swelling, Rash pruritic, Asthenia, Heart rate decreased, Vomiting, Dizziness, Abdominal pain, Abdominal tenderness, Rash papular, Diarrhoea, Fatigue, Nausea, Decreased appetite, Injection site mass, Injection site pain, Injection site pain, Injection site reaction, Injection site erythema, Needle issue, |
||||
AMLODIPINE, AMLODIPINE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLOPIDOGREL, CLOPIDOGREL BISULFATE, |
||||
| 739 | 26911947 |
US |
77 | 2 |
Abdominal pain, Pyrexia, Urinary tract infection, Diverticulitis, Vomiting, Cerebral haemorrhage, |
||||
INFLIXIMAB, |
||||
| 740 | 26912032 |
JP |
118 | 2 |
Seizure, Pyrexia, Tremor, Hypersensitivity, Staring, Withdrawal syndrome, Tachycardia, Agitation, Vomiting, |
||||
DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN SODIUM CHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE, DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE, |
||||
| 741 | 26912183 |
US |
35 | |
Vomiting, Nausea, Diarrhoea, Abdominal pain, |
||||
DULAGLUTIDE, LIRAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 742 | 26912191 |
US |
2 | |
Vomiting, Nausea, |
||||
TIRZEPATIDE, |
||||
| 743 | 26912201 |
US |
2 | |
Nausea, Dizziness, Vomiting, |
||||
ORFORGLIPRON, |
||||
| 744 | 26912252 |
US |
||
Nausea, Vomiting, Drug ineffective, |
||||
SUZETRIGINE, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 745 | 26912323 |
EU |
23 | 2 |
Coma, Seizure, Vomiting, Drug abuse, |
||||
PREGABALIN, PREGABALIN, |
||||
| 746 | 26912434 |
US |
64 | 2 |
Breast cancer female, Urinary bladder suspension, Dizziness, Vomiting, Psoriasis, Uterine dilation and curettage, Dizziness, Post procedural complication, Vertigo, |
||||
RISANKIZUMAB-RZAA, |
||||
| 747 | 26912497 |
CN |
77 | 2 |
Myelosuppression, Vomiting, Nausea, Abdominal distension, |
||||
VENETOCLAX, |
||||
| 748 | 26912542 |
BR |
2 | |
White blood cell count decreased, Abdominal pain, Viral infection, Diarrhoea, Leukopenia, Metastasis, Head discomfort, Reaction to excipient, Blood pressure abnormal, Anxiety, Nail discomfort, Constipation, Decreased immune responsiveness, Abdominal discomfort, Platelet count decreased, Flatulence, Tension, Laziness, Blood test, Illness, Patient-device incompatibility, Nervousness, Insomnia, Lymphoedema, Platelet count abnormal, Malaise, Pain, Abdominal distension, Abdominal discomfort, Gastrointestinal pain, Nausea, White blood cell count decreased, Pyrexia, Fatigue, Abdominal pain upper, Alopecia, Platelet count decreased, Headache, Nausea, Headache, Pain in extremity, Abdominal pain, Pain, Vomiting, |
||||
FULVESTRANT, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FULVESTRANT, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 749 | 26912560 |
CA |
43 | 2 |
Abdominal discomfort, Weight increased, Rash, Wound, Abdominal pain upper, Irritable bowel syndrome, Retinitis, Vomiting, Memory impairment, Visual impairment, Musculoskeletal pain, Maternal exposure during pregnancy, Paraesthesia, Hepatic enzyme increased, General physical health deterioration, Impaired healing, C-reactive protein increased, Lung disorder, Psoriatic arthropathy, Joint range of motion decreased, Glossodynia, Red blood cell sedimentation rate increased, Anti-cyclic citrullinated peptide antibody positive, Dislocation of vertebra, Folliculitis, Taste disorder, Pain, Bursitis, Migraine, Asthenia, Peripheral swelling, Hypocholesterolaemia, Joint swelling, Dry mouth, Exostosis, Diarrhoea, Headache, Decreased appetite, Depression, Night sweats, Blister, Lupus vulgaris, Gastrooesophageal reflux disease, Peripheral venous disease, Blepharospasm, Breast cancer stage III, Dizziness, Arthralgia, Infusion related reaction, Pericarditis, Frequent bowel movements, Feeling hot, Osteoporosis, Synovitis, Exposure during pregnancy, Contraindicated product administered, Pyrexia, Back injury, Product quality issue, Blood cholesterol increased, Muscle spasms, |
||||
SECUKINUMAB, SECUKINUMAB, TOFACITINIB, TOFACITINIB CITRATE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, LEFLUNOMIDE, LEFLUNOMIDE, MEPOLIZUMAB, OXYCODONE, OXYCODONE, TOFACITINIB, TOFACITINIB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, PHENYLEPHRINE HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, INFLIXIMAB, PYRIDOXINE HYDROCHLORIDE, CANDESARTAN, CANDESARTAN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, MINOCYCLINE HYDROCHLORIDE, APREMILAST, APREMILAST, BUPRENORPHINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, CYCLOBENZAPRINE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, MIRABEGRON, MIRABEGRON, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, GOLIMUMAB, GOLIMUMAB, ERENUMAB-AOOE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, PREDNISONE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, TRAMADOL HYDROCHLORIDE, RAMIPRIL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ABATACEPT, ABATACEPT, CELECOXIB, CELECOXIB, NAPROXEN, NAPROXEN SODIUM, RANITIDINE HYDROCHLORIDE, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, VITAMIN C, SULFASALAZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FISH OIL, QUETIAPINE FUMARATE, QUETIAPINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RISEDRONATE SODIUM, ALBUTEROL SULFATE, LISINOPRIL, |
||||
| 750 | 26912565 |
US |
2 | |
Vomiting, |
||||
TIRZEPATIDE, |
||||
| 751 | 26912582 |
IN |
60 | 2 |
Death, Metastases to central nervous system, Oedema peripheral, Decreased appetite, Nausea, Dizziness, Fall, Vomiting, |
||||
CRIZOTINIB, GABAPENTIN, |
||||
| 752 | 26912644 |
IN |
55 | 2 |
Vomiting, Mucosal inflammation, Gastritis, Multi-organ disorder, Haematotoxicity, Bicytopenia, Toxicity to various agents, Accidental overdose, Product dispensing error, Drug interaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, RABEPRAZOLE, RABEPRAZOLE, RABEPRAZOLE, RABEPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, |
||||
| 753 | 26912686 |
EU |
47 | 1 |
Spinal fracture, Gait disturbance, Impaired gastric emptying, Ileus paralytic, Seizure, Multiple acyl-coenzyme A dehydrogenase deficiency, Myalgia, Muscle spasms, Muscular weakness, Muscle twitching, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE HYDROCHLORIDE, |
||||
| 754 | 26912699 |
US |
59 | 2 |
Vomiting, Headache, Diarrhoea, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 755 | 26912763 |
US |
||
Hypertension, Vomiting, |
||||
POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 756 | 26912773 |
US |
||
Hypertension, Vomiting, |
||||
POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, |
||||
| 757 | 26912781 |
EU |
24 | 1 |
Pneumonia aspiration, Dysphagia, Vomiting, |
||||
CLOZAPINE, RISPERIDONE, QUETIAPINE, QUETIAPINE, VALPROIC ACID, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 758 | 26912865 |
US |
52 | 2 |
Dyspnoea, Vomiting, Immune system disorder, Illness, Chills, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ALBUTEROL SULFATE, TIRZEPATIDE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, ROPINIROLE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, FLUOXETINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, FAMOTIDINE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MIDODRINE HYDROCHLORIDE, ALBUTEROL SULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, ESZOPICLONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, EPINEPHRINE, ADRENALINUM, GABAPENTIN, |
||||
| 759 | 26912919 |
CA |
43 | 2 |
Pulmonary fibrosis, Alopecia, Product use issue, Psoriatic arthropathy, Rheumatoid arthritis, Drug tolerance decreased, Pain, Vomiting, Rheumatic fever, Joint swelling, Musculoskeletal stiffness, Infusion related reaction, Nausea, Therapeutic product effect decreased, Gastrointestinal disorder, Synovitis, Maternal exposure during pregnancy, X-ray abnormal, Rheumatoid factor positive, Product use in unapproved indication, Gait disturbance, Mobility decreased, General physical health deterioration, Pemphigus, Anti-cyclic citrullinated peptide antibody positive, Abdominal discomfort, Pneumonia, Dyspepsia, Arthropathy, Liver injury, Type 2 diabetes mellitus, Contraindicated product administered, Migraine, Live birth, Pericarditis, Drug ineffective, Fatigue, Glossodynia, Hypersensitivity, Swollen joint count increased, Systemic lupus erythematosus, Wound, Incorrect route of product administration, Duodenal ulcer perforation, Hypertension, Blood cholesterol increased, Intentional product use issue, Treatment failure, Drug intolerance, Blister, Discomfort, Rash, Off label use, Hepatic enzyme increased, Arthralgia, Headache, Hand deformity, Swelling, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SECUKINUMAB, SECUKINUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MORPHINE SULFATE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, |
||||
| 760 | 26912998 |
US |
64 | 2 |
Vomiting, Nausea, Neoplasm, Brain injury, Anosmia, Ageusia, Blindness, |
||||
ONABOTULINUMTOXINA, |
||||
| 761 | 26913046 |
US |
78 | 1 |
Neoplasm malignant, Diarrhoea, Flatulence, Abdominal distension, Vomiting, Feeling abnormal, Fatigue, Muscular weakness, |
||||
PANCRELIPASE, PANCRELIPASE, |
||||
| 762 | 26913140 |
EU |
64 | 2 |
Hyperkalaemia, Gamma-glutamyltransferase increased, Vomiting, |
||||
CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DURVALUMAB, |
||||
| 763 | 26913197 |
US |
5 | 2 |
Depressed level of consciousness, Vomiting, Accidental exposure to product by child, Product use issue, |
||||
| 764 | 26913287 |
EU |
11 | 2 |
Crohn^s disease, Clostridium difficile infection, Cytomegalovirus infection, Diarrhoea, Weight decreased, Vomiting, Drug ineffective, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, |
||||
| 765 | 26913297 |
CA |
2 | |
General physical health deterioration, Pulmonary fibrosis, Duodenal ulcer perforation, Abdominal discomfort, Alopecia, Arthropathy, Asthma, Autoimmune disorder, Blood cholesterol increased, Chest pain, Confusional state, Contusion, Decreased appetite, Deep vein thrombosis postoperative, Discomfort, Dizziness, Drug intolerance, Dyspepsia, Irritable bowel syndrome, Liver injury, Lower limb fracture, Mobility decreased, Muscle injury, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Pain, Pemphigus, Pericarditis, Pneumonia, Pruritus, Psoriatic arthropathy, Fatigue, Fibromyalgia, Folliculitis, Gait inability, Glossodynia, Hand deformity, Headache, Helicobacter infection, Hypertension, Hypoaesthesia, Impaired healing, Pyrexia, Rash, Rheumatic fever, Rheumatoid arthritis, Road traffic accident, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wound, Prescribed overdose, Drug ineffective, Maternal exposure during pregnancy, Exposure during pregnancy, Contraindicated product administered, Off label use, Product use in unapproved indication, Incorrect route of product administration, Product use issue, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, VITAMIN C, VITAMIN C, VITAMIN C, TOFACITINIB, CORTISONE ACETATE, DESOXIMETASONE, DESOXIMETASONE, ETANERCEPT, ETANERCEPT, ADALIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 766 | 26913308 |
US |
1 | |
Diarrhoea, Nausea, Vomiting, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 767 | 26913405 |
EU |
48 | 1 |
Acute kidney injury, Vomiting, |
||||
CYCLOSPORINE, |
||||
| 768 | 26913420 |
GB |
35 | 2 |
Pancreatitis, Lipase increased, Melaena, Decreased appetite, Faeces discoloured, Diarrhoea, Vomiting, Abdominal discomfort, Abdominal pain, |
||||
TIRZEPATIDE, TIRZEPATIDE, HYDROXYCHLOROQUINE SULFATE, |
||||
| 769 | 26913422 |
CA |
40 | 2 |
Pneumonia, Migraine, Depression, Dyspepsia, Systemic lupus erythematosus, Hepatitis, Back injury, Blister, Vomiting, Peripheral venous disease, Hypertension, Malaise, Osteoarthritis, Joint swelling, Coeliac disease, Abdominal distension, Bursitis, Hypercholesterolaemia, Taste disorder, Hypersensitivity, Rheumatic fever, Arthropathy, Contusion, Fibromyalgia, Injury, Dry mouth, Rheumatoid arthritis, Gait inability, Infusion related reaction, Nail disorder, Arthralgia, Dyspnoea, Insomnia, Drug hypersensitivity, Synovitis, Gastrointestinal disorder, Stomatitis, Helicobacter infection, Neck pain, Psoriatic arthropathy, Hypoaesthesia, Sleep disorder, Injection site reaction, Irritable bowel syndrome, Onychomadesis, Duodenal ulcer perforation, Pericarditis, Nasopharyngitis, Hand deformity, Pemphigus, Alopecia, |
||||
SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ERENUMAB-AOOE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ETANERCEPT, ETANERCEPT, FOLIC ACID, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, MEPOLIZUMAB, TOFACITINIB, TOFACITINIB, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, |
||||
| 770 | 26913448 |
71 | 1 | |
Vomiting, Diarrhoea, Faeces discoloured, Weight decreased, Thrombocytopenia, Nausea, Prostatic abscess, |
||||
LINEZOLID, DAPTOMYCIN, |
||||
| 771 | 26913454 |
|||
Vomiting, Confusional state, Disturbance in attention, Brain fog, Balance disorder, Fatigue, |
||||
OBINUTUZUMAB, |
||||
| 772 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 773 | 26913584 |
CA |
44 | 2 |
Liver injury, Vomiting, Sinusitis, Type 2 diabetes mellitus, Therapy non-responder, Headache, Swelling, Hypersensitivity, Stomatitis, Rheumatic fever, Swollen joint count increased, Wheezing, Hypertension, Ill-defined disorder, Gastrointestinal disorder, Hypoaesthesia, Impaired healing, Insomnia, General physical health deterioration, Weight increased, Inflammation, Urticaria, Sleep disorder due to general medical condition, insomnia type, Irritable bowel syndrome, Rash, Nasopharyngitis, Helicobacter infection, Sleep disorder, Pyrexia, Blister, Pruritus, Treatment failure, Therapeutic product effect decreased, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ALENDRONATE SODIUM, PANTOPRAZOLE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, DICLOFENAC SODIUM, SECUKINUMAB, LEFLUNOMIDE, CALCIUM GLUCONATE, CORTISONE ACETATE, CORTISONE ACETATE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALENDRONATE SODIUM, GOLIMUMAB, |
||||
| 774 | 26913587 |
US |
2 | |
Atrial fibrillation, Nausea, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 775 | 26913631 |
US |
||
Eye operation, Malaise, Memory impairment, Vomiting, Adverse reaction, |
||||
VUTRISIRAN, |
||||
| 776 | 26913654 |
EU |
47 | 1 |
Impaired gastric emptying, Ileus paralytic, Seizure, Spinal fracture, Multiple acyl-coenzyme A dehydrogenase deficiency, Gait disturbance, Muscular weakness, Muscle spasms, Muscle twitching, Myalgia, Nausea, Vomiting, Product label issue, |
||||
SERTRALINE, |
||||
| 777 | 26913769 |
BR |
63 | 2 |
Acute myeloid leukaemia, Second primary malignancy, Septic shock, Somnolence, Pyrexia, Hypotension, Chills, Dyspnoea, Multiple organ dysfunction syndrome, Nervous system disorder, Cardiovascular disorder, Renal impairment, Hepatic function abnormal, Neutrophil count decreased, Cytokine release syndrome, Pyrexia, Hypotension, Febrile neutropenia, Febrile neutropenia, Pyrexia, Leukopenia, Haemoglobin decreased, Thrombocytopenia, Pneumonia, Skin reaction, Wheezing, Haemorrhage, Cough, Hyperaemia, Pruritus, Purpura, Contusion, Pancytopenia, Platelet count decreased, Lymphocyte count decreased, Vitreous haemorrhage, Acute kidney injury, Blood alkaline phosphatase increased, Blood urea increased, Eosinophil count decreased, Monocyte count decreased, White blood cell count decreased, Serum ferritin increased, Fibrin D dimer increased, Nausea, Vomiting, Pain in extremity, Tremor, Somnolence, Constipation, Fatigue, Oedema peripheral, Gingival bleeding, Hepatic mass, Odynophagia, Back pain, Erythema, Petechiae, Asthenia, Headache, Epistaxis, Pain in extremity, Paraesthesia, Pain in extremity, Dry mouth, |
||||
TISAGENLECLEUCEL, CEFEPIME HYDROCHLORIDE, CEFEPIME, MEROPENEM, |
||||
| 778 | 26913805 |
GB |
44 | 2 |
Lymphadenopathy, Hyperhidrosis, Paraesthesia, Pain in extremity, Diarrhoea, Vomiting, |
||||
TIRZEPATIDE, COLESEVELAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 779 | 26913807 |
EU |
24 | 1 |
Mucous stools, Abdominal pain lower, Nausea, Vomiting, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 780 | 26913811 |
US |
2 | |
Abdominal discomfort, Nausea, Skin swelling, Vomiting, Dry skin, Pruritus, |
||||
DUPILUMAB, ERGOCALCIFEROL, |
||||
| 781 | 26913844 |
US |
1 | |
Muscular weakness, Vomiting, Joint swelling, |
||||
SIBEPRENLIMAB, |
||||
| 782 | 26913959 |
EU |
20 | 1 |
Prothrombin time shortened, Poisoning deliberate, Vomiting, |
||||
ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 783 | 26913988 |
CA |
44 | 2 |
Blister, Gastrointestinal disorder, General physical health deterioration, Headache, Helicobacter infection, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Insomnia, Irritable bowel syndrome, Liver injury, Nasopharyngitis, Pruritus, Pyrexia, Rash, Rheumatic fever, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ALENDRONATE SODIUM, LEFLUNOMIDE, VEDOLIZUMAB, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, GOLIMUMAB, PANTOPRAZOLE, SECUKINUMAB, ASCORBIC ACID, |
||||
| 784 | 26913990 |
US |
37 | 2 |
Diarrhoea, Headache, Mood swings, Illness, Nausea, Vomiting, |
||||
ORAL SEMAGLUTIDE, |
||||
| 785 | 26914069 |
US |
23 | 2 |
Diarrhoea, Gastroenteritis viral, Pyrexia, Vomiting, Hypotension, Dizziness, Weight decreased, Injection site swelling, Injection site pain, Injection site erythema, |
||||
SIBEPRENLIMAB, SIBEPRENLIMAB, BUDESONIDE, TIRZEPATIDE, |
||||
| 786 | 26914183 |
US |
93 | |
Hypertension, Headache, Vomiting, Off label use, |
||||
RUXOLITINIB, CARBIDOPA AND LEVODOPA, RASAGILINE MESYLATE, RASAGILINE, FINASTERIDE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, |
||||
| 787 | 26914320 |
US |
51 | 1 |
Suicidal ideation, Abdominal discomfort, Vomiting, |
||||
XANOMELINE AND TROSPIUM CHLORIDE, XANOMELINE AND TROSPIUM CHLORIDE, |
||||
| 788 | 26914495 |
43 | 2 | |
Abdominal discomfort, Abdominal pain upper, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage II, Breast cancer stage III, Bursitis, C-reactive protein increased, Contraindicated product administered, Decreased appetite, Depression, Diarrhoea, Dislocation of vertebra, Dizziness, Dry mouth, Exostosis, Feeling hot, Folliculitis, Frequent bowel movements, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Headache, Hepatic enzyme increased, Hypocholesterolaemia, Impaired healing, Inflammation, Infusion related reaction, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lung disorder, Lupus vulgaris, Memory impairment, Migraine, Muscle spasms, Musculoskeletal pain, Night sweats, Osteoporosis, Pain, Paraesthesia, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Red blood cell sedimentation rate increased, Retinitis, Synovitis, Taste disorder, Visual impairment, Vomiting, Weight increased, Wound, Live birth, Exposure during pregnancy, Maternal exposure during pregnancy, Product quality issue, Product use in unapproved indication, |
||||
BETAMETHASONE DIPROPIONATE, |
||||
| 789 | 26914539 |
US |
65 | 2 |
Myocardial infarction, Extremity contracture, Paraesthesia, Blood potassium decreased, Vomiting, Glycosylated haemoglobin increased, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 790 | 26914602 |
GB |
34 | 2 |
Hypotension, Pain, Nausea, Hypoaesthesia, Vomiting, Diarrhoea, |
||||
PEMBROLIZUMAB, |
||||
| 791 | 26919001 |
2 | ||
Abdominal pain, Faeces discoloured, Nausea, Vomiting, |
||||
TADALAFIL, |
||||
| 792 | 26919002 |
2 | ||
Abdominal pain, Faeces discoloured, Nausea, Vomiting, |
||||
MACITENTAN, |
||||
| 793 | 26919299 |
35 | 2 | |
Vomiting, Hypersensitivity, Drug ineffective, |
||||
PANTOPRAZOLE, FAMOTIDINE, |
||||
| 794 | 26925060 |
64 | 2 | |
Weight decreased, Vomiting, Nonspecific reaction, Diabetic ketoacidosis, |
||||
CEMIPLIMAB-RWLC, |
||||
| 795 | 26904550 |
US |
2 | |
Nausea, Product use in unapproved indication, Vomiting, Headache, Dyspepsia, Abdominal pain upper, Presyncope, |
||||
| 796 | 26904619 |
EU |
55 | |
Choroidal effusion, Urinary retention, Sciatica, Discomfort, Depressed mood, Sensitivity to weather change, Decreased appetite, Post procedural complication, Diarrhoea, Speech disorder, Sticky skin, Blood pressure decreased, Limb discomfort, Nervousness, White blood cell count decreased, Haemoglobin decreased, Parosmia, Asthenia, Muscle spasms, Weight decreased, Decreased immune responsiveness, Pain, Gastrointestinal pain, Gastric pH decreased, Increased appetite, Chills, Gallbladder disorder, Cystitis, Tremor, Pain in extremity, Dysuria, Dizziness postural, Urine abnormality, Arthralgia, Weight increased, Malaise, Injection site pain, Dysuria, Dehydration, Alopecia, Gait disturbance, Mental disorder, Nipple disorder, Muscle spasms, Feeling abnormal, Insomnia, Dry skin, Abdominal distension, Dyspepsia, Fatigue, Nausea, Vomiting, Constipation, Abdominal pain upper, Toxicity to various agents, Vomiting, Nausea, Abdominal pain, Abdominal discomfort, Cystitis, Palpitations, Daydreaming, |
||||
LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, MORPHINE, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, DIMENHYDRINATE, DIMENHYDRINATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, FULVESTRANT, PHYTONADIONE, CALCIUM, ERGOCALCIFEROL, FULVESTRANT, MENADIONE, |
||||
| 797 | 26904639 |
CN |
63 | 1 |
Nausea, Vomiting, Ketosis, |
||||
| 798 | 26904641 |
US |
32 | 1 |
HIV infection, Vomiting, Product use issue, Product use in unapproved indication, |
||||
ORAL SEMAGLUTIDE, |
||||
| 799 | 26904651 |
EU |
19 | 2 |
Suicidal ideation, Intentional self-injury, Vomiting, Intentional product use issue, Intentional overdose, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 800 | 26904796 |
US |
34 | 2 |
Nausea, Vomiting, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
